ニュートラシューティカルズ市場：製品種類別、形状別、用途別、地域別（2026～2032年）

ニュートラシューティカルズ市場の評価（2026～2032年）

生活習慣病を管理するために予防医療ソリューションや栄養補助食品を求める傾向が強くなっている消費者の健康意識の高まりが、ニュートラシューティカルズ市場を牽引する主な要因となっています。ニュートラシューティカルズ市場は、2024年の収益3,842億7,000万米ドルを下回り、2032年には4,537億8,000万米ドルに達すると推計されます。

技術と調査の進歩が革新的なニュートラシューティカルズ処方を生み出し、市場は2026年から2032年までCAGR 2.10%で成長します。

ニュートラシューティカルズ市場定義／概要

ニュートラシューティカルズ（Nutraceutical）とは、基本的な栄養以上の健康効果をもたらす食品と定義され、健康維持や病気の予防に用いられることが多いです。「栄養」と「医薬品」を組み合わせたこの用語には、栄養補助食品や機能性食品、漢方薬など幅広い製品が含まれます。

ニュートラシューティカルズは、生理学的な利点や慢性疾患からの保護を提供すると考えられており、健康の増進、老化の遅延、身体の構造や機能の強化に利用することができます。ニュートラシューティカルズは食品由来ですが、一般的に医薬品に似た形で販売されており、医薬品のような厳密な科学的検証を受けていない可能性があります。ニュートラシューティカルズの規制上の位置づけは国によって異なり、医薬品ではなく食品やサプリメントとして扱う国もあります。

高齢化はニュートラシューティカルズ市場の成長においてどのような役割を果たすか？

高齢化社会はニュートラシューティカルズ市場の成長促進要因として重要であると認識されています。2030年までに世界の6人に1人が60歳以上になると報告されており、この人口層に合わせた健康に焦点を当てたソリューションの緊急性が浮き彫りになっています。高齢化が進むにつれて、加齢に伴う疾病の予防が重視されるようになり、関節の健康、認知機能、心臓血管の健康を促進する栄養補助食品や機能性食品に対する需要が高まっています。

政府の統計によると、慢性疾患に関連する医療費用は上昇しており、高齢者がニュートラシューティカルズを通じて予防的医療対策を採用するよう促しています。

さらに、高齢者が栄養補助食品を日常生活に取り入れることを推奨する傾向が強まっていることが研究で示されており、この分野の成長余地をさらに押し上げています。ニュートラシューティカルズの消費を通じて健康維持と疾病予防を優先する個人が増えるにつれて、この人口動態の変化は市場動向に影響を与え続けると予想されます。

ニュートラシューティカルズ市場における品質管理と標準化に関する主な課題は何か？

品質管理と標準化は、主に医薬品と比較して厳しい規制基準がないことに起因する、ニュートラシューティカルズ市場における主要課題です。消費者の約70％が栄養補助食品の品質と安全性に懸念を表明していることが報告されており、強固な品質保証対策の必要性が強調されています。成分の自然なばらつきは、しばしばバッチ間の不一致をもたらし、製品の有効性を損ない、消費者の信頼を損なう可能性があります。

政府の統計によれば、多くの製造業者が適正製造規範（GMP）の遵守を怠り、製造中の汚染や品質問題のリスクを招いています。その結果、高品質の基準を維持する責任は、厳格な検査プロトコルを実施し、製造工程全体を通じてトレーサビリティを確保しなければならない個々のメーカーにますます大きくなっています。品質に関する普遍的に認められたベンチマークがないため、ニュートラシューティカルズ業界では、製品の信頼性と消費者の安全性を確保する上で大きな課題が残っています。

目次

第1章 世界のニュートラシューティカルズ市場：イントロダクション

• 市場概要
• 分析範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの分析手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界のニュートラシューティカルズ市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界のニュートラシューティカルズ市場：製品種類別

• 概要
• 栄養補助食品
• 機能性食品
• 医療用栄養
• 機能性飲料

第6章 世界のニュートラシューティカルズ市場：形状別

• 概要
• 錠剤
• 粉末
• 液体
• グミ

第7章 世界のニュートラシューティカルズ市場：用途別

• 概要
• 予防医療
• 疾病管理
• 体重管理
• アンチエイジング

第8章 世界のニュートラシューティカルズ市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• その他の地域 (ROW)
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界のニュートラシューティカルズ市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Pfizer Inc.
• Nestle Health Science S.A.
• Amway Corporation
• Herbalife Nutrition Ltd.
• DSM
• The Hain Celestial Group, Inc.
• Abbott Laboratories
• Danone S.A.
• Sun Pharmaceutical Industries Ltd.
• NutraLife Corporation

第11章 付録

• 関連分析

Nutraceutical Market Valuation - 2026-2032

The increasing health consciousness among consumers, who are more inclined to seek preventive healthcare solutions and dietary supplements to manage lifestyle-related disorders are the primary factor driving the nutraceutical market. The Nutraceutical Market is estimated to reach a valuation of USD 453.78 Billion by 2032 over the forecast by subjugating the revenue of USD 384.27 Billion valued in 2024.

Advancements in technology and research have led to innovative nutraceutical formulations, enabling the market to grow at a CAGR of 2.10% from 2026 to 2032.

Nutraceutical Market: Definition/ Overview

A nutraceutical is defined as a food product that provides health benefits beyond basic nutrition, often used to maintain health and prevent illness. The term, which combines "nutrition" and "pharmaceutical," encompasses a wide range of products, including dietary supplements, functional foods, and herbal remedies.

Nutraceuticals are believed to offer physiological benefits or protection against chronic diseases and can be utilized to improve health, delay aging, and enhance the body's structure or function. While they are derived from food sources, nutraceuticals are typically marketed in forms resembling medicinal products and may not have undergone the same rigorous scientific validation as pharmaceuticals. The regulatory status of nutraceuticals varies by country, with some jurisdictions treating them as foods or dietary supplements rather than drugs.

What Role does the Aging Population Play in Driving the Growth of the Nutraceutical Market?

The aging population is recognized as a significant driver of growth in the nutraceutical market, as an increasing number of individuals over the age of 65 are seeking products that support their health and well-being. It has been reported that by 2030, one in six people worldwide will be aged 60 years or older, highlighting the urgency for health-focused solutions tailored to this demographic. As people age, there is a heightened emphasis on preventing age-related diseases, leading to a greater demand for dietary supplements and functional foods that promote joint health, cognitive function, and cardiovascular wellness.

Government statistics indicate that healthcare costs associated with chronic diseases are rising, prompting older adults to adopt preventive healthcare measures through nutraceuticals.

Additionally, studies have shown that older adults are increasingly recommended to incorporate dietary supplements into their daily routines, further boosting the scope for growth in this sector. This demographic shift is expected to continue influencing market trends as more individuals prioritize health maintenance and disease prevention through nutraceutical consumption.

What are the Main Challenges Related to Quality Control and Standardization in the Nutraceutical Market?

Quality control and standardization are major challenges in the nutraceutical market, primarily due to the lack of stringent regulatory standards compared to pharmaceuticals. It has been reported that approximately 70% of consumers express concerns regarding the quality and safety of dietary supplements, which underscores the necessity for robust quality assurance measures. The natural variability of ingredients often results in batch-to-batch inconsistencies, potentially compromising product efficacy and eroding consumer trust.

Government statistics highlight that many manufacturers fail to adhere to Good Manufacturing Practices (GMP), leading to risks of contamination and quality issues during production. As a result, the responsibility for maintaining high-quality standards increasingly falls on individual manufacturers, who must implement rigorous testing protocols and ensure traceability throughout the production process. Without universally accepted benchmarks for quality, significant challenges persist in ensuring product reliability and consumer safety within the nutraceutical industry.

Category-Wise Acumens

How do Consumer Preferences for Natural Health Solutions Contribute to the Dominance of Dietary Supplements in the Nutraceutical Market?

Consumer preferences for natural health solutions significantly contribute to the dominance of dietary supplements in the nutraceutical market, as an increasing number of individuals are gravitating towards products perceived as safer and more effective for health maintenance. It has been reported that approximately 70% of consumers express a preference for natural ingredients, particularly for preventive health measures rather than curative ones, indicating a strong inclination towards dietary supplements that promise enhanced well-being without the side effects often associated with synthetic medications.

Government statistics from the Ministry of Food Processing Industries highlight a notable shift in purchasing patterns, with many consumers now favoring immunity-boosting supplements and herbal products over traditional pharmaceuticals for minor health issues. This trend is further supported by a growing awareness of the health benefits associated with dietary supplements, which is reflected in the increasing consumer willingness to invest in products that align with their values of sustainability and natural wellness. As a result, the nutraceutical market is being shaped by these evolving consumer preferences, leading to a robust demand for dietary supplements that cater to the desire for holistic health solutions.

How has the COVID-19 Pandemic Influenced the Emphasis on Preventive Healthcare Within the Nutraceutical Market?

The COVID-19 pandemic has significantly influenced the emphasis on preventive healthcare within the nutraceutical market, as consumers increasingly seek solutions to enhance their immunity and overall health. It has been observed that the demand for dietary supplements surged during the pandemic, with many individuals turning to nutraceuticals as a proactive measure against health threats. Government data from the Food Safety and Standards Authority of India (FSSAI) indicate that there was a notable shift in consumer behavior, with a marked increase in the purchase of immunity-boosting supplements such as vitamins C and D, zinc, and probiotics. Approximately 15% of India's population is reported to be undernourished, highlighting the critical role that nutraceuticals can play in addressing nutritional deficiencies exacerbated by the pandemic.

Furthermore, initiatives such as the National Health Mission have underscored the importance of nutrition in public health policies, thereby reinforcing the relevance of nutraceuticals as essential components of preventive healthcare strategies. As a result, a lasting impact on consumer attitudes towards health and wellness has been established, positioning nutraceuticals as vital tools in promoting preventive care in a post-pandemic world.

What Factors Contribute to North America's Position as a Leader in the Nutraceutical Market?

North America's position as a leader in the global nutraceutical market is influenced by several key factors, primarily driven by consumer demand for health-focused products. It has been reported that approximately 35.2% of the nutraceutical market share is held by this region, reflecting a strong preference for preventive healthcare solutions among consumers. Government statistics from the Centers for Disease Control and Prevention (CDC) indicate that nearly 70% of adults in the U.S. are seeking dietary supplements to enhance their health and prevent chronic diseases. The aging population in North America also plays a crucial role, as older adults increasingly turn to nutraceuticals to manage age-related health issues.

Additionally, rising healthcare costs, which account for about 14% of the U.S. gross national product, have prompted consumers to seek cost-effective preventive measures through dietary supplements and functional foods. Furthermore, regulatory support for functional food innovations and increased research and development efforts by companies are fostering a competitive environment that enhances product availability and consumer trust in nutraceuticals. As a result, these factors collectively contribute to North America's dominant position in the nutraceutical market.

What Factors Contribute to the Rapid Growth of the Nutraceutical Market in Asia Pacific Region?

The rapid growth of the nutraceutical market in the Asia Pacific region is driven by several key factors, primarily related to changing consumer preferences and increasing health awareness. It has been reported that approximately 40% of the demand for nutraceuticals originated from Asia Pacific in 2022, reflecting a strong regional inclination towards preventive healthcare solutions. Government statistics from the World Health Organization indicate that the prevalence of chronic diseases such as diabetes and cardiovascular conditions is rising, prompting consumers to seek dietary supplements to enhance their health and immunity.

Additionally, various government initiatives, including the Poshan Abhiyan in India aimed at eradicating malnutrition, have promoted awareness about the importance of nutrition in disease prevention. Furthermore, the legalization of hemp cultivation in several countries has led to an increase in cannabis-based nutraceutical products, catering to evolving consumer interests. As a result, these factors collectively contribute to the dynamic expansion of the nutraceutical market in the Asia Pacific region, positioning it as a significant player on the global stage.

Competitive Landscape

The competitive landscape of the nutraceutical market is characterized by a mix of established international players and emerging companies, all striving for market share through innovation and strategic initiatives. The rising trend of veganism and clean-label products is influencing product formulations, leading to increased demand for botanical ingredients. With an advanced distribution network supporting these efforts, the competitive dynamics within the nutraceutical market are expected to continue evolving as companies adapt to changing consumer preferences and health trends.

Some of the prominent players operating in the nutraceutical market include:

Pfizer,

Nestle Health Science A.

Amway Corporation

Herbalife Nutrition

DSM

The Hain Celestial Group,

Abbott Laboratories

Danone A.

Sun Pharmaceutical Industries

NutraLife Corporation

Latest Developments

In March 2023, Pfizer announced a definitive merger agreement to acquire Seagen Inc. for USD 43 Billion, aiming to enhance its oncology portfolio and potentially expand into nutraceutical applications that support cancer treatment and overall health.

In February 2023, DSM launched life's(R)OMEGA O3020, a new algal oil product aimed at providing a sustainable alternative to fish oil, addressing consumer demand for plant-based omega-3 fatty acids.

Nutraceutical Market, By Category Product Type:

• Dietary Supplements
• Functional Foods
• Medical Nutrition
• Functional Beverages
• Form:
• Tablets
• Powders
• Liquids
• Gummies
• Application:
• Preventive Healthcare
• Disease Management
• Weight Management
• Anti-Aging
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NUTRACEUTICAL MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NUTRACEUTICAL MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Dietary Supplements
• 5.3 Functional Foods
• 5.4 Medical Nutrition
• 5.5 Functional Beverages

6 GLOBAL NUTRACEUTICAL MARKET, BY FORM

• 6.1 Overview
• 6.2 Tablets
• 6.3 Powders
• 6.4 Liquids
• 6.5 Gummies

7 GLOBAL NUTRACEUTICAL MARKET, BY APPLICATION

• 7.1 Overview
• 7.2 Preventive Healthcare
• 7.3 Disease Management
• 7.4 Weight Management
• 7.5 Anti-Aging

8 GLOBAL NUTRACEUTICAL MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL NUTRACEUTICAL MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Pfizer Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Nestle Health Science S.A.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Amway Corporation
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Herbalife Nutrition Ltd.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 DSM
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 The Hain Celestial Group, Inc.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Abbott Laboratories
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Danone S.A.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Sun Pharmaceutical Industries Ltd.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 NutraLife Corporation
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Reports